GlaxoSmithKline

Category: CFDs

13-01-2011

GlaxoSmithKline is a core defensive holding, a global pharmaceutical giant that is diversifying away
from blockbuster drugs into emerging market generics and consumer healthcare. The shares are
cheap and are supported by a high dividend yield.

For short-term traders, we are advising buying the stock via a CFD with a 1277p target price and setting a stop loss at 1195p.

Remember, trading is about probabilities, not certainties, so base the position size on the capital in your account. Do not risk more than 5% on each trade. By having a risk/return ratio of at least 2:1 we are targeting a profit that is substantially bigger than the potential loss meaning that over time you should win more than you lose.

Read